Advanced Genomic Services

Veterans of Next Generation Sequencing: Ambry scientists have been working with NGS platforms since 2007. In 2008, Ambry became the 3rd Illumina certified sequencing provider in the world and began offering contract research services to the biotech and pharmaceutical industries. Ambry scientists were among the first to perform whole exome sequencing, create custom gene panels using custom probe design and obtain certified service provider status from Roche-Nimble and Agilent. Ambry has leveraged this extensive knowledge to develop the most accurate and cutting-edge diagnostic tests in the industry. We are seasoned experts that can take your project from concept to completion. Our entire CAP/CLIA menu can be used for contract research or we can design custom assays to meet your needs.

Adventitious Virus Detection

Whole Genome, Exome & Clinical Sequencing Learn More

Custom Bio-informatics & Database Solutions Learn More

Tumor Genomic
Profiling
Learn More

ctDNA Analysis

Whole Transcriptome Sequencing and
Targeted RNA-seq
Learn More

Immuno-oncology Biomarker Analysis

Pathology/Histology

Custom Assay Development

Drug development and companion diagnostics require a quality lab partner. Our state-of-the-art laboratory and professional services can help you develop and validate custom assays designed to provide much-needed therapies to those impacted by cancer and a wide range of hereditary disorders. Our lab has identified the gene(s), designed the assay, and brought to market more than 500 unique diagnostic tests, and can customize a test that meets your specific criteria.

The Management Team

Ambry’s CLIA-approved CAP-certified, New York approved lab boasts more than 65,000 sq. feet of highly-automated equipment, optimized for everything from large scale, volume testing to customized research projects. Our comprehensive end-to-end Precision Medicine workflow includes the following platforms:

  • Illlumina Sequencing
  • Affymetrix CytoScan, OncoScan and Gene Expression
  • Agilent Arrays
  • Probe-based Target Enrichment from IDT, Agilent and Roche
  • ArcherDX FusionPlex and Immunoverse

Ambry has a department of professionals dedicated to managing and administering key elements of our Quality Management System (QMS). We maintain our Service Organization Control (SOC2) Certification through the implementation of strict guidelines for:

  • Licensure & credentialing
  • Disaster recovery
  • Proficiency testing
  • Document control
  • Training & competency
  • Sample chain of custody

All Ambry tests are developed and validated in full compliance with all federal, state and local laws, rules and regulations; including CLIA, New York State and CAP standards. Our test performance is routinely and closely monitored to ensure the timely delivery of accurate test results to our clients and their patients.

In Partnership With

>1 Million Samples Tested

Search Results

Start your search...